文献速递瓣膜外科

经二尖瓣室间隔心肌切除术治疗肥厚型梗阻性心肌病

Transmitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy.
PubMed 文献 · Ann Thorac Surg · 2018-02-14

回顾性分析20例经二尖瓣行室间隔心肌切除术的肥厚型梗阻性心肌病患者,70%为女性,平均年龄63岁。术前左心室流出道峰值压差92±43 mm Hg,出院前降至10±5 mm Hg,无手术死亡,随访22±25个月无再手术及左心室流出道梗阻或中度以上二尖瓣反流复发。作者认为经二尖瓣途径可全景显露室间隔及二尖瓣瓣下结构并同期处理二尖瓣病变,应考虑将其作为肥厚型心肌病外科治疗的首选途径。

要点

  • 经二尖瓣行室间隔心肌切除术可全景显露室间隔及二尖瓣瓣下结构。
  • 该途径可同期行二尖瓣修复或置换,本组修复11例、置换9例。
  • 本组无手术死亡,随访无再手术及左心室流出道梗阻复发。

核心结论

  • 经二尖瓣心肌切除术的潜在优势包括全景显露室间隔及二尖瓣瓣下结构,并能同期处理二尖瓣病变。
  • 作者认为应考虑将经二尖瓣途径作为肥厚型心肌病外科治疗的首选途径。

研究设计与样本

  • 回顾性连续纳入接受经二尖瓣室间隔心肌切除术的患者。
  • 共识别20例患者,70%为女性,平均年龄63岁。
  • 手术经左心房切开显露室间隔,将二尖瓣前叶从瓣环上剥离,行扩大心肌切除术至乳头肌基底部,之后重新附着前叶并同期行二尖瓣修复或置换。
  • 部分病例采用改良的前外侧交界闭合缝线(「幕状缝线」),将前叶外侧部分移出左心室流出道。

主要发现

  • 术前二尖瓣反流中度者占55%,重度者占40%。
  • 术前左心室流出道峰值压差为92±43 mm Hg。
  • 行二尖瓣修复11例,二尖瓣置换9例。
  • 出院前经胸超声心动图显示左心室流出道压差为10±5 mm Hg。
  • 无手术死亡,随访完整率100%,平均随访22±25个月,无患者需再手术,无左心室流出道梗阻复发或二尖瓣反流大于轻度复发。

临床怎么用

  • 作者认为应考虑将经二尖瓣途径作为肥厚型心肌病外科治疗的首选途径。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intrinsic abnormalities of the mitral valve are common in patients with hypertrophic cardiomyopathy and may need to be addressed at operation. METHODS: Consecutive patients undergoing transmitral septal myectomy were retrospectively reviewed. The ventricular septum was exposed through a left atriotomy, and the anterior leaflet of the mitral valve was detached from its annulus. An extended myectomy was performed to the base of the papillary muscles. After myectomy, the anterior leaflet was reattached and concomitant mitral valve repair or replacement was performed. In some cases, we performed a modified anterolateral commissural closure suture, which served to reposition the lateral aspect of the anterior leaflet out of the left ventricular outflow tract ("curtain stitch"). RESULTS: Twenty patients who underwent this procedure were identified (70% women; mean age 63 years). Mitral regurgitation was moderate in 55% and severe in 40%. Preoperative peak left ventricular outflow tract gradient was 92 ± 43 mm Hg. Mitral valve repair (n = 11) or replacement (n = 9) was performed. Predischarge transthoracic echocardiography demonstrated a left ventricular outflow tract gradient of 10 ± 5 mm Hg. There was no operative mortality. Follow-up was 100% complete and averaged 22 ± 25 months. No patient required reoperation, and there was no recurrence of left ventricular outflow tract obstruction or mitral regurgitation greater than mild. CONCLUSIONS: Potential advantages of transmitral myectomy include a panoramic view of the septum and mitral subvalvular apparatus and the ability to simultaneously address mitral valve pathology. Consideration should be given to using the transmitral approach to septal myectomy as the preferred approach for the surgical treatment of hypertrophic cardiomyopathy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Wehman B, Ghoreishi M, Foster N, et al. Transmitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy. Ann Thorac Surg. 2018. PMID: 29453001. doi:10.1016/j.athoracsur.2017.10.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。